SEARCH Articles Figures Tables 4- Point pharmacophores privileged Asymmetric catalysis privileged ligands Attorney—client privilege Biphenyls privileged structures Carboxylic acids privileged structures Central nervous system immune privilege Chiral catalysts, “privileged Clinical privileges, defined Combinatorial chemistry privileged fragments Combinatorial chemistry privileged structures DIVERSITY-ORIENTED SYNTHESIS OF PRIVILEGED HETEROCYCLES USING DIVERGENT STRATEGY Immune privilege Immune privilege ocular Lead compounds privileged structures Lead discovery privileged structures Libraries privileged Libraries, combinatorial privileged structures Library design privileged substructures Library privileged scaffold Phosphines privileged Privileged Privileged Privileged Ligands Privileged Structures Bind to Many Different Targets Privileged Structures and Substructures in the Design of Pharmacologically Relevant Combinatorial Libraries Privileged Structures with Undesired Target Profiles Privileged bodies Privileged building blocks Privileged catalysts Privileged centres Privileged documents Privileged fragments Privileged pharmacophores Privileged scaffolds Privileged structural motifs Privileged structures Privileged structures, definition Privileged substructures Privileged substructures, structure-activity Privileged templates Privileged versus Peripheral Retrosynthetic Fragments Privileges and immunities Privileging, defined Structure privileged structures Technical Secretariats proposed text for bilateral Agreements on Privileges and Immunities under Article VIII, paragraph